212 POSTER A Phase I study of huC242-DM4 to assess the safety and pharmacokinetics of huC242-DM4 administered as a single intravenous infusion once every three weeks to subjects with solid tumors

✍ Scribed by A.W. Tolcher; A. Ricart; J. Rodon; A. Patnaik; A. Mita; M. Mita; S. Sarantopolus; S. Zildjian; J. Watermill; R.J. Fram

• Book ID: 118623840
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 66 KB
• Volume: 4
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(06)70217-8